XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Retained earnings
AOCI
Deferred Compensation, Share-Based Payments
Beginning balance (in shares) at Dec. 31, 2023   34,906,233      
Beginning balance at Dec. 31, 2023 $ 853,261 $ 549,748 $ 375,989 $ (72,476)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock units vested (in shares)   113,188      
Restricted stock units vested 0        
Stock-based compensation expense 1,006       $ 1,006
Twelfth Stock Repurchase Plan, Common Stock, Repurchased Shares (in shares)   (329,578)      
Common stock repurchased (6,118) $ (6,118)      
Net income 5,748   5,748    
Other comprehensive income, net of tax 1,791     1,791  
Cash dividends declared on common stock 8,108   8,108    
Ending balance (in shares) at Mar. 31, 2024   34,689,843      
Ending balance at Mar. 31, 2024 $ 847,580 $ 544,636 373,629 (70,685)  
Beginning balance (in shares) at Dec. 31, 2024 33,990,827 33,990,827      
Beginning balance at Dec. 31, 2024 $ 863,527 $ 531,674 387,097 (55,244)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock units vested (in shares)   149,937      
Restricted stock units vested 0        
Stock-based compensation expense 1,288       $ 1,288
Twelfth Stock Repurchase Plan, Common Stock, Repurchased Shares (in shares)   (35,248)      
Common stock repurchased (838) $ (838)      
Net income 13,911   13,911    
Other comprehensive income, net of tax 11,898     11,898  
Cash dividends declared on common stock $ 8,271   8,271    
Ending balance (in shares) at Mar. 31, 2025 34,105,516 34,105,516      
Ending balance at Mar. 31, 2025 $ 881,515 $ 532,124 $ 392,737 $ (43,346)